[Taylor&Francis] Disproportionality analysis of the safety profile of rufinamide in the real world: an evaluation of the FDA Adverse Event Reporting System database |
|
This post will be closed automatically in 2026-07-09 23:16
Reward30points
|
30
Adverse events of nusinersen: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
30
Disproportionality analysis of the safety profile of rufinamide in the real world: an evaluation of the FDA Adverse Event Reporting System database
50
Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology
30
Hunters and Gatherers (Vol I)
30
Mobile money an antidote to petty corruption? A matched difference-in-differences analysis
